Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Retatrutide is a triple agonist (GIP, GLP-1, and glucagon receptors) while Ozempic activates only GLP-1 receptors, resulting in significantly greater weight loss, 24.2% versus 14.9% at standard doses
While there is evidence that some ingredients may promote GLP-1 production in the body 8,9 , there is little evidence that these can reduce body fat long-term 10
Prabha et al., 2025)
Hepatoprotective peptides target multiple stages of this damage cascade reducing inflammation, neutralizing oxidative stress, blocking fibrosis pathways, and supporting hepatocyte survival
This is why a personalized program, like the ones offered through our platform, involves a medical screening to check for pre-existing risks
The ability of Retatrutide to reverse adipose tissue dysfunction suggests its potential utility not only in obesity but also in related metabolic disorders characterized by ectopic lipid deposition, such as metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM) [14, 50]
